NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 665522 | Null | 0.00366577979610627 | -0.37921463 |
NSC 711103 | Null | 0.00374367388796147 | 0.15946027 |
NSC 725670 | 5,6-Dihydro-5,11-dioxo-6-(2-N-piperazine-1-ethyl)-11H-indeno [1,2-c]isoquinoline | 0.00374367388796147 | -0.17740285 |
NSC 756170 | GSK317315A | 0.00374367388796147 | -0.13222386 |
NSC 627371 | 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- | 0.00414350254426684 | -0.10182266 |
NSC 641691 | Vicenistatin | 0.00414350254426684 | -0.30018383 |
NSC 726627 | thiadiazines | 0.00414350254426684 | -0.31179776 |
NSC 735424 | 2-(3-(hydroxymethyl)phenylamino)-6-(2,6-dichlorophenyl)-8-me thylpyrido[2,3-d]pyrimidin-7(8H)-one | 0.00414350254426684 | 0.0036046043 |
NSC 639517 | Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride | 0.00418964244951812 | -0.2547966 |
NSC 669145 | 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- | 0.00418964244951812 | -0.25782945 |